Defining categories of actionability for secondary findings in next-generation sequencing.

Abstract excerpt

Next-generation sequencing is increasingly used in clinical practice for the diagnosis of Mendelian diseases. Because of the high likelihood of secondary findings associated with this technique, the process of informing patients is beset with new challenges. One of them is regarding the type of secondary findings that ought to be disclosed to patients. The aim of this research is to propose a practical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to High-Throughput Nucleotide Sequencing
• Share to Genetic Diseases, Inborn